ABOS Acumen Pharmaceuticals, Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$2.23
Price · May 20, 2026
Fundamentals as of May 12, 2026

ABOS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$2.23
Market Cap
$128M
P/E (TTM)
-1.1
EPS (TTM)
$-2.00
Revenue (TTM)
Div Yield
ROE
-129.4%
Debt/Equity
0.1
52W Range
$1 – $4

ABOS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS $-2.00
5-point trend, +60.2%
2021-12-31 2025-12-31
Free Cash Flow $-116M
5-point trend, -542.3%
2021-12-31 2025-12-31
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
ABOS
Peer Median
P/E (TTM)
5-point trend, +21.7%
-1.1
16.5
P/B
5-point trend, +49.4%
1.8
2.2
EV / EBITDA
-0.2
Price / FCF
5-point trend, +92.7%
-1.1

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
ABOS
Peer Median
ROA
5-point trend, +8.4%
-67.1%
-65.8%
ROE
5-point trend, -194.9%
-129.4%
-80.6%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
ABOS
Peer Median
Debt / Equity
0.1
216.2
Current Ratio
4-point trend, -82.4%
4.1
3.7
Quick Ratio
4-point trend, -36.0%
3.9

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
ABOS
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
ABOS
Peer Median
EPS (Diluted)
5-point trend, +60.2%
$-2.00

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
ABOS
Peer Median

ABOS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 12 analysts
  • Strong Buy 6 50.0%
  • Buy 5 41.7%
  • Hold 1 8.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

5 analysts · 2026-05-15
Median target $8.00 +258.7%
Mean target $7.40 +231.8%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.04%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.33 $-0.41 0.08%
Dec. 31, 2025 $-0.41 $-0.46 0.05%
Sept. 30, 2025 $-0.44 $-0.62 0.18%
June 30, 2025 $-0.68 $-0.55 -0.13%
March 31, 2025 $-0.48 $-0.68 0.20%
Dec. 31, 2024 $-0.62 $-0.49 -0.13%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ABOS $128M -1.1 -129.4%
RNAC $188M -1.4 -92.8% -4658.6% 202.4%
CRBP $143M -1.4 -60.8%
KPTI $135M -0.4 0.57% -134.2% 73.7%
TNYA $154M -1.2 -81.2%
HRTX $245M -10.8 7.4% -13.0% 312.5% 73.3%
HURA -1.2
IMUX -0.9
SPRO $131M 15.5 39.2% 12.8% 18.7%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 14
Annual Income Statement data for ABOS
Metric Trend 202520242023202220212020
R&D Expense 6-point trend, +1211.6% $105M $94M $42M $32M $12M $8M
SG&A Expense 6-point trend, +1302.4% $19M $20M $19M $13M $7M $1M
Operating Expenses 6-point trend, +1224.7% $124M $114M $61M $45M $20M $9M
Operating Income 6-point trend, -1465.1% $-124M $-114M $-61M $-45M $-20M $-8M
Interest Expense 2-point trend, +581000.00 · · $581.0K $0 · ·
Interest Income 4-point trend, +211.3% $7M $14M $11M $2M · ·
Other Non-op 5-point trend, -621.6% $-266.0K $-151.0K $-83.0K $-11.0K $51.0K ·
Income Tax Flat — no change across 6 periods $0 $0 $0 $0 $0 $0
Net Income 6-point trend, -1556.5% $-121M $-102M $-52M $-43M $-101M $-7M
EPS (Basic) 5-point trend, +60.2% $-2.00 $-1.71 $-1.08 $-1.06 $-5.02 ·
EPS (Diluted) 5-point trend, +60.2% $-2.00 $-1.71 $-1.08 $-1.06 $-5.02 ·
Shares (Basic) 5-point trend, +201.9% 60,561,836 60,013,277 48,609,383 40,601,936 20,057,534 ·
Shares (Diluted) 5-point trend, +201.9% 60,561,836 60,013,277 48,609,383 40,601,936 20,057,534 ·
EBITDA 5-point trend, -532.3% $-124M $-114M $-61M $-45M $-20M ·
Balance Sheet 25
Annual Balance Sheet data for ABOS
Metric Trend 202520242023202220212020
Cash & Equivalents 6-point trend, +23.3% $54M $36M $67M $130M $122M $44M
Short-term Investments 5-point trend, -12.8% $63M $136M $177M $48M $72M ·
Prepaid Expense 6-point trend, +892.1% $5M $7M $3M $3M $4M $543.0K
Other Current Assets 3-point trend, +102.1% · · $283.0K $237.0K $140.0K ·
Current Assets 6-point trend, +175.2% $122M $178M $247M $180M $199M $44M
PP&E (Net) 5-point trend, +186.1% $103.0K $73.0K $122.0K $165.0K $36.0K ·
Accum. Depreciation 3-point trend, +100.0% $200.0K $100.0K $100.0K · · ·
Other Non-current Assets 6-point trend, +350000.00 $350.0K $486.0K $724.0K $151.0K $14.0K $0
Total Assets 6-point trend, +176.5% $123M $239M $310M $197M $230M $44M
Accounts Payable 6-point trend, +4.3% $554.0K $6M $1M $2M $1M $531.0K
Accrued Liabilities 4-point trend, +200.7% $10M $7M $6M $3M · ·
Short-term Debt 2-point trend, +8765000.00 $9M $0 · · · ·
Current Liabilities 5-point trend, +483.0% $30M $28M $13M $8M $5M ·
Capital Leases 3-point trend, +150000.00 · $150.0K $284.0K $0 · ·
Other Non-current Liabilities 3-point trend, -100.0% $0 $150.0K $284.0K · · ·
Total Liabilities 6-point trend, +723.0% $52M $57M $43M $8M $5M $6M
Long-term Debt 4-point trend, +22396000.00 $22M $29M $30M $0 · ·
Total Debt $9M · · · · ·
Common Stock 5-point trend, +50.0% $6.0K $6.0K $6.0K $4.0K $4.0K ·
Paid-in Capital 6-point trend, +6071.5% $517M $507M $489M $360M $353M $8M
Retained Earnings 6-point trend, -1555.7% $-446M $-325M $-223M $-170M $-128M $-27M
AOCI 4-point trend, +111.1% $83.0K $-48.0K $312.0K $-751.0K · ·
Stockholders' Equity 6-point trend, +478.8% $70M $182M $267M $189M $225M $-19M
Liabilities + Equity 6-point trend, +176.5% $123M $239M $310M $197M $230M $44M
Shares Outstanding 6-point trend, +14352.9% 60,575,369 60,094,083 57,910,461 41,025,062 40,473,270 419,124
Cash Flow 9
Annual Cash Flow data for ABOS
Metric Trend 202520242023202220212020
Stock-based Comp 6-point trend, +6297.4% $10M $10M $6M $3M $922.0K $154.0K
Operating Cash Flow 6-point trend, -1450.8% $-116M $-86M $-43M $-35M $-18M $-7M
CapEx 5-point trend, +120.0% $88.0K $16.0K $21.0K $161.0K $40.0K ·
Investing Cash Flow 5-point trend, +228.6% $134M $48M $-172M $39M $-104M ·
Stock Issued 5-point trend, -100.0% $0 $8M $122M $4M $169M ·
Net Stock Activity 5-point trend, -100.0% $0 $8M $122M $4M $169M ·
Financing Cash Flow 6-point trend, -100.1% $-34.0K $7M $152M $4M $200M $45M
Taxes Paid Flat — no change across 6 periods $0 $0 $0 $0 $0 $0
Free Cash Flow 5-point trend, -542.3% $-116M $-86M $-43M $-35M $-18M ·
Profitability 2
Annual Profitability data for ABOS
Metric Trend 202520242023202220212020
ROA 5-point trend, +8.4% -67.1% -37.3% -20.7% -20.1% -73.2% ·
ROE 5-point trend, -194.9% -129.4% -51.3% -19.1% -22.2% -43.9% ·
Liquidity & Solvency 4
Annual Liquidity & Solvency data for ABOS
Metric Trend 202520242023202220212020
Current Ratio 4-point trend, -82.4% 4.1 6.5 19.0 23.1 · ·
Quick Ratio 4-point trend, -36.0% 3.9 6.2 18.8 6.1 · ·
Debt / Equity 0.1 · · · · ·
Interest Coverage · · -105.2 · · ·
Per Share 4
Annual Per Share data for ABOS
Metric Trend 202520242023202220212020
Book Value / Share 5-point trend, -79.1% $1.16 $3.03 $4.61 $4.60 $5.56 ·
Cash Flow / Share 4-point trend, -120.4% $-1.91 $-1.44 $-0.89 $-0.87 · ·
Cash / Share 4-point trend, -70.5% $0.89 $0.59 $1.16 · $3.02 ·
EPS (TTM) 5-point trend, +60.2% $-2.00 $-1.71 $-1.08 $-1.06 $-5.02 ·
Valuation (TTM) 11
Annual Valuation (TTM) data for ABOS
Metric Trend 202520242023202220212020
Net Income TTM 5-point trend, -20.6% $-121M $-102M $-52M $-43M $-101M ·
Market Cap 5-point trend, -53.3% $128M $103M $222M $222M $274M ·
Enterprise Value $20M · · · · ·
P/E 5-point trend, +21.7% -1.1 -1.0 -3.6 -5.1 -1.3 ·
P/B 5-point trend, +49.4% 1.8 0.6 0.8 1.2 1.2 ·
P / Tangible Book 5-point trend, +49.4% 1.8 0.6 0.8 1.2 1.2 ·
P / Cash Flow 5-point trend, +92.7% -1.1 -1.2 -5.2 -6.3 -15.2 ·
P / FCF 5-point trend, +92.7% -1.1 -1.2 -5.2 -6.3 -15.2 ·
EV / EBITDA -0.2 · · · · ·
EV / FCF -0.2 · · · · ·
Earnings Yield 5-point trend, -27.6% -94.8% -99.4% -28.1% -19.6% -74.3% ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Net Income $-121M$-102M$-52M$-43M$-101M
Diluted EPS $-2.00$-1.71$-1.08$-1.06$-5.02
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 0.1
Current Ratio 4.16.519.023.1
Quick Ratio 3.96.218.86.1
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-116M$-86M$-43M$-35M$-18M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.